Literature DB >> 28438297

Investigating a case of possible field cancerization in oral squamous cell carcinoma by the use of next-generation sequencing.

Siavosh Tabatabaeifar1, Martin J Larsen2, Stine R Larsen3, Torben A Kruse2, Mads Thomassen2, Jens A Sørensen4.   

Abstract

OBJECTIVES: Local recurrence and the development of second primary tumors (SPT) are important factors that can influence the survival rate of oral squamous cell carcinoma (OSCC) patients. We investigate the concept of field cancerization which proposes that normal tissue adjacent to the primary tumor harbor pre-neoplastic alterations that can lead to the development of local recurrence and SPTs.
MATERIALS AND METHODS: To examine the concept of field cancerization, we applied whole-exome and targeted ultra-deep sequencing on 5 freshly frozen samples from a stage III OSCC patient from three tumor sites, lymph node metastasis and blood. Lastly, we sequenced one formalin-fixed paraffin-embedded recurrence biopsy that was collected approximately a year and half later located in the same area as before.
RESULTS: Sequencing identified 126 somatic mutations. We identified 24 mutations in the recurrence biopsy and 14 mutations are shared by the primary tumor.
CONCLUSION: The low number of shared mutations indicates that either these mutations represent a very early clone in the primary tumor's evolution, or that these mutations represent a pre-neoplastic field, in which the primary tumor and recurrence are derived from. In both instances, the clinical recurrence is of a monoclonal origin which suggests either field cancerization by migration of mutated cells in the adjacent mucosa, or that the recurrence developed out of remaining tumor tissue.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Field cancerization; Oral squamous cell carcinoma; Recurrence; Second field tumor; Subclonal structure; Tumor heterogeneity; Ultra-deep sequencing

Mesh:

Year:  2017        PMID: 28438297     DOI: 10.1016/j.oraloncology.2017.03.018

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  4 in total

1.  Malignant transformation of oral epithelial dysplasia in Southwest Finland.

Authors:  Toni T Nevanpää; Antti E Terävä; Hanna K Laine; Jaana Rautava
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

2.  Prognostic ability of DNA-binding protein inhibitor ID-1 expression in patients with oral squamous cell carcinoma.

Authors:  Jian Chen; Fan Zhang; Dong Wang; Zhongjun Yang; Shaohua Liu; Zuoqing Dong
Journal:  Oncol Lett       Date:  2020-04-02       Impact factor: 2.967

3.  Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression.

Authors:  Arnab Ghosh; Chitrarpita Das; Sandip Ghose; Arindam Maitra; Bidyut Roy; Partha P Majumder; Nidhan K Biswas
Journal:  J Pathol       Date:  2022-04-21       Impact factor: 9.883

Review 4.  Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.

Authors:  Liang Zhong; Yutong Liu; Kai Wang; Zhijing He; Zhaojian Gong; Zhili Zhao; Yaocheng Yang; Xiaofei Gao; Fangjie Li; Hanjiang Wu; Sheng Zhang; Lin Chen
Journal:  BMC Cancer       Date:  2018-09-21       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.